Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small cell lung cancer (NSCLC): analysis of toxicity and local control

Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small... J Radiat Oncol (2017) 6:247–253 DOI 10.1007/s13566-016-0289-9 ORIGINAL RESEARCH Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small cell lung cancer (NSCLC): analysis of toxicity and local control 1,2 1 1 1 John Bowers & Nathan R. Bennion & Martin Richardson & Kelly Spencer & 3 1,3 James Larner & Ronald Kersh Received: 12 September 2016 /Accepted: 2 November 2016 /Published online: 26 November 2016 Springer-Verlag Berlin Heidelberg 2016 Abstract Eleven patients failed locally giving a 2-year actuarial local Purpose/objectives Stereotactic body radiation therapy for control rate of 80.7%, with control rates of 82.5 and 79.2% for centrally located lung tumors has been associated with in- primary and recurrent tumors, respectively (p =0.828). creased risk of toxicity. A current study aims to evaluate tumor Regional control at 2 years was not significantly different for control and toxicity in large cohort of centrally located lesions. primary (72.6%) and recurrent (62.7%). Analysis of toxicity Methods Central location was defined as tumors within 2 cm revealed no grade 4 or 5 events. One grade 3 event was re- of the bronchial tree, trachea, major vessels, esophagus, heart, ported as pneumonitis. Grade 2 toxicity occurred in 10 pa- pericardium, brachial http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Radiation Oncology Springer Journals

Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small cell lung cancer (NSCLC): analysis of toxicity and local control

Loading next page...
 
/lp/springer_journal/stereotactic-body-radiation-therapy-sbrt-for-centrally-located-primary-pFdmwcM5AW
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2016 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Imaging / Radiology; Cancer Research; Surgical Oncology; Surgery; Radiotherapy
ISSN
1948-7894
eISSN
1948-7908
D.O.I.
10.1007/s13566-016-0289-9
Publisher site
See Article on Publisher Site

Abstract

J Radiat Oncol (2017) 6:247–253 DOI 10.1007/s13566-016-0289-9 ORIGINAL RESEARCH Stereotactic body radiation therapy (SBRT) for centrally located primary and recurrent non-small cell lung cancer (NSCLC): analysis of toxicity and local control 1,2 1 1 1 John Bowers & Nathan R. Bennion & Martin Richardson & Kelly Spencer & 3 1,3 James Larner & Ronald Kersh Received: 12 September 2016 /Accepted: 2 November 2016 /Published online: 26 November 2016 Springer-Verlag Berlin Heidelberg 2016 Abstract Eleven patients failed locally giving a 2-year actuarial local Purpose/objectives Stereotactic body radiation therapy for control rate of 80.7%, with control rates of 82.5 and 79.2% for centrally located lung tumors has been associated with in- primary and recurrent tumors, respectively (p =0.828). creased risk of toxicity. A current study aims to evaluate tumor Regional control at 2 years was not significantly different for control and toxicity in large cohort of centrally located lesions. primary (72.6%) and recurrent (62.7%). Analysis of toxicity Methods Central location was defined as tumors within 2 cm revealed no grade 4 or 5 events. One grade 3 event was re- of the bronchial tree, trachea, major vessels, esophagus, heart, ported as pneumonitis. Grade 2 toxicity occurred in 10 pa- pericardium, brachial

Journal

Journal of Radiation OncologySpringer Journals

Published: Nov 26, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off